| 2024-04-11 | -0.21 % |
|
| 2024-04-05 | +0.28 % |
|
| 2024-04-04 | -1.13 % |
|
| 2024-04-01 | -1.39 % |
|
| 2024-03-27 | +1.69 % |
|
| 2024-03-26 | +0.17 % |
|
| 2024-03-25 | -0.19 % |
|
| 2024-03-19 | +0.87 % |
|
| 2024-03-15 | -1.08 % |
|
| 2024-03-12 | -0.27 % |
- The article discusses how institutional investors have increased their holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) stock, with Townsquare Capital LLC boosting its position by 37.2% and other investors like Moneta Group Investment Advisors LLC and Norges Bank also acquiring shares, and analysts providing positive ratings for the stock. The stock went down last night by -0.27% due to general market conditions and profit-taking from investors after a recent increase in stock price.
- Summary: Toroso Investments LLC increased its stake in IDEXX Laboratories, Inc. by 12.7% in the 3rd quarter, with other large investors also buying shares; meanwhile, the company's CFO and SVP have been selling stock, leading to a decline in IDEXX Laboratories stock by -0.27% last night.
Reason for stock decline: While there could be several factors influencing the stock decline, the recent selling of shares by company insiders, including the CFO and SVP, amounting to a considerable value, could have impacted investor confidence and contributed to the decrease in IDEXX Laboratories stock price.
|
| 2024-03-11 | -2.33 % |
|
| 2024-03-01 | +0.29 % |
- The article discusses LPL Financial LLC boosting its position in IDEXX Laboratories, Inc. (IDXX) and several other institutional investors modifying their holdings, contributing to IDXX stock edging up by 0.29%, with potential reasons including strong earnings results, positive analyst ratings, and substantial investments from institutions.
- Summary: O Shaughnessy Asset Management LLC increased its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 16.3% in the 3rd quarter and several other institutional investors also adjusted their holdings in the company; with the stock rising by 0.29% last night, likely attributed to the increased institutional investments and positive analyst recommendations.
Reason for the stock increase: The stock of IDEXX Laboratories (IDXX) went up as institutional investors, such as O Shaughnessy Asset Management LLC, and other large investors increased their stakes in the company, which often indicates confidence in the company's future prospects, leading to the stock's upward momentum. Additionally, positive analyst recommendations and the company's strong earnings results further contributed to the stock's increase.
|
| 2024-02-29 | +0.62 % |
- The article discusses the situation at Elanco Animal Health, where investment firm Ancora Holdings is pushing for board seats and the replacement of the CEO due to poor performance, leading to a 0.62% increase in Idexx Laboratories' stock price last night.
- The article discusses the positive performance of Elanco Animal Health Incorporated (NYSE: ELAN) stock, which has seen a 39% increase over the past year and reached a 52-week high earlier this week. The stock goes up due to Elanco's successful execution of its Innovation, Portfolio, and Productivity strategy, which has led to growth and progress in their pipeline, generating further growth and shareholder rewards.
- The article discusses Covestor Ltd increasing its position in IDEXX Laboratories, Inc. stock by 71.8% and other institutional investors also adding to their stakes, leading to a positive upward trend in the stock price, likely influenced by strong earnings data and analyst ratings.
|
| 2024-02-28 | -0.59 % |
|
| 2024-02-27 | +0.91 % |
|
| 2024-02-26 | -1.11 % |
- The article discusses Meiji Yasuda Asset Management Co Ltd. increasing its holdings in IDEXX Laboratories, Inc. (IDXX) by 8.9% during the 3rd quarter, and several other large investors making changes to their positions in the business; however, IDXX stock went down due to various factors, such as institutional investor transactions, market performance, and analyst reports.
- The article discusses Natixis Advisors L.P. selling a portion of its stake in IDEXX Laboratories, Inc. (IDXX), which led to the stock being down by -1.11% the previous night, and mentions other institutional investors adjusting their holdings, while also highlighting recent insider selling of company stock. The stock price decrease is attributed to the reduction in ownership by a major investor possibly causing market uncertainty.
- Summary: Natixis Advisors L.P. reduced its holdings in IDEXX Laboratories, Inc. (IDXX) by 9.2% in the third quarter, with various other institutional investors also adjusting their positions in the company; IDXX stock was down -1.11% last night, likely influenced by this divestment and changes in ownership.
Reason for IDXX stock decline: The decrease in IDEXX Laboratories' stock price may have been affected by Natixis Advisors L.P. and other institutional investors trimming their positions in the company, leading to selling pressure and potentially impacting market sentiment.
|
| 2024-02-23 | +0.87 % |
|
| 2024-02-20 | -0.78 % |
- The article discusses how WINTON GROUP Ltd reduced its position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 4.8% in the 3rd quarter. IDXX stock went down, likely influenced by various hedge funds making changes to their positions in the company, with WINTON GROUP Ltd selling some shares.
- The article discusses Envestnet Asset Management Inc. increasing its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 21.4% in the 3rd quarter, with other hedge funds also making modifications to their holdings. IDXX stock went down by -0.78%, possibly influenced by insider selling activity as detailed in the article, including shares sold by the CFO and CEO.
- The article discusses IDEXX Laboratories, Inc. (NASDAQ: IDXX) participating in upcoming conferences and providing live audio webcasts through its website, highlighting the company's role as a global leader in pet healthcare innovation. The reason for the -0.78% decrease in IDXX stock could be due to various factors influencing the stock market such as overall market conditions, industry-specific news, or investor sentiment.
|
| 2024-02-13 | -1.75 % |
|
| 2024-02-07 | +0.94 % |
|
| 2024-02-06 | -0.89 % |
|
| 2024-02-05 | +8.53 % |
|
| 2024-02-02 | -0.03 % |
|
| 2024-01-30 | -2.07 % |
|
| 2024-01-25 | +0.43 % |
|
| 2024-01-23 | +0.02 % |
|
| 2024-01-22 | +1.45 % |
|
| 2024-01-19 | -0.28 % |
|
| 2024-01-12 | -4.19 % |
|
| 2023-12-13 | +2.3 % |
|
| 2023-12-12 | +1.66 % |
|
| 2023-12-11 | +0.9 % |
|
| 2023-12-08 | +1.58 % |
|
| 2023-12-07 | +0.29 % |
|
| 2023-12-06 | +0.5 % |
|
| 2023-12-04 | +7.05 % |
|
| 2023-11-27 | +0.3 % |
|
| 2023-11-22 | +0.13 % |
|
| 2023-11-15 | +1.39 % |
|
| 2023-11-13 | +0.85 % |
|
| 2023-11-06 | -1.46 % |
|
| 2023-11-03 | +2.35 % |
|
| 2023-11-02 | +6.09 % |
|
| 2023-11-01 | -1.03 % |
|
| 2023-10-31 | +0.78 % |
|
| 2023-10-27 | -1.52 % |
|
| 2023-10-23 | +0.17 % |
|
